HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lithium compound treatment and psoriasis.

Abstract
Observations were made of 12 cases of psoriasis that developed and three cases of psoriasis that became exacerbated during treatment with lithium compounds. Only two patients had a family history of psoriasis, and results of a search for increased frequencies of the histocompatibility antigens seen in psoriasis vulgaris were negative. The clinical features were identical to severe psoriasis vulgaris and the diagnosis was confirmed by histologic examination performed in six cases. However, the skin changes disappeared or returned to pretreatment level after withdrawal of lithium compounds. A positive provocation test result was obtained in two cases, the secondary latency time being shorter than the primary. We suggest that the psoriasis was induced or exacerbated by lithium compounds.
AuthorsI Skoven, J Thormann
JournalArchives of dermatology (Arch Dermatol) Vol. 115 Issue 10 Pg. 1185-7 (Oct 1979) ISSN: 0003-987X [Print] United States
PMID507859 (Publication Type: Journal Article)
Chemical References
  • Histocompatibility Antigens
  • Lithium
Topics
  • Adult
  • Aged
  • Bipolar Disorder (drug therapy)
  • Female
  • Histocompatibility Antigens (immunology)
  • Humans
  • Lithium (adverse effects)
  • Male
  • Middle Aged
  • Psoriasis (chemically induced, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: